1 April 2018 - The April 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
27 March 2018 - PHARMAC is seeking feedback on a proposal to list aflibercept (Eylea) and rivaroxaban (Xarelto) through a ...
1 March 2018 - The March 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
1 February 2018 - PHARMAC is working to make the Pharmaceutical Schedule Rules easier to find, use and apply. ...
1 February 2018 - The February 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
24 January 2018 - Following assessment of bids in PHARMAC’s 2017/18 annual Invitation to Tender, PHARMAC is proposing to fund ...
21 December 2018 - Funding cetuximab for patients with head and neck cancer will be a significant advance for treating ...
1 January 2018 - The January 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
1 December 2017 - The December 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
16 November 2017 - In a proposal released this week, PHARMAC has announced its intention to fund the HIV-prevention drug ...
15 November 2017 - PHARMAC is seeking feedback on a proposal to make several changes to the funding of medicines ...
14 November 2017 - PHARMAC is seeking feedback on three proposals to widen funded access, from 1 January 2018, to ...
9 November 2017 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe & Dohme to ...
8 November 2017 - PHARMAC is seeking feedback on a proposal to list methylnaltrexone bromide (Relistor) 12 mg/0.6 mL injection in ...
1 November 2017 - The November 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...